Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Vaccine stocks have taken a hit after an FDA official suggested a link between COVID-19 vaccines and a rare heart condition in young men. The memo also mentions potential concerns with flu and pneumonia vaccines, casting a broader shadow over the industry. Market sentiment has turned bearish as investors reassess the risks associated with these vaccines.